Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- A doctor has diagnosed you with moderate to severe plaque psoriasis
- You are about to start treatment with a medication called deucravacitinib for the first time
- You are willing to take part in the study
Who may not be able to join:
- You are currently taking part in, or planning to join, another clinical trial that involves a treatment or intervention
- You have previously taken deucravacitinib at any point, including as part of another study where you may not have known which treatment you were receiving
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Physician's Global Assessment (PGA) 0/1 response; Dermatology Life Quality Index (DLQI) 0/1 response; Time from date of treatment initiation to date of discontinuation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.